Autonomous mobility startup Metawave closes series A funding round
Category: #business  By Mateen Dalal  Date: 2019-11-07
  • share
  • Twitter
  • Facebook
  • LinkedIn

Autonomous mobility startup Metawave closes series A funding round

 

  • The investment aims at carrying out development of smart radar mechanisms for autonomous cars
  • Metawave is also developing active repeaters and passive relays to help deploy 5G technology

 

Metawave Corporation – a U.S. based startup transforming the radar sensing technology for automated driving and wireless solutions for the deployment of 5G, has reportedly completed a series A funding round led by DENSO, world’s second-largest mobility supplier.  

For the record, the funding round witnessed participation from new Metawave investors, NTT DOCOMO Ventures and Mirae Asset Capital and other existing Metawave investor, BOLD Capital Partners.

With the investment, Denso aims to utilize Metawave’s technological expertise to accelerate the development of a smart radar system for driverless vehicles.  

Metawave is constantly investing and carrying out developments in radar sensing with the help of its state-of-the-art analog radar that offers long-range, superior angular accuracy, higher resolution, and intelligent object classification when compared to conventional radars.

Such characteristics will allow automakers to facilitate vehicles with next-gen adaptive cruise control, automated emergency braking and lane change assist. The analog-radar enabled features assist in enhancing road safety and the possibility that advanced driver assistance systems are well-received in the long-term. 

According to Tony Cannestra, director of corporate ventures at DENSO, the company has been closely working with Metawave since its establishment and bets on the innovations created and delivered by their team. Lately, automakers are making huge investments in autonomous vehicles with the need to facilitate innovations in the radar system, he further added.

Apparently, along with developing the radar sensors, Metawave is also developing TURBO™ active repeaters and ECHO™ passive relays to provide support towards the implementation of 5G. the platforms provide efficient, faster and economical modes of 5G deployment to ensure reliable, continuous and high-speed connectivity to billions of users across stadiums, office buildings, cities and under service areas across the globe.

Founder and CEO of Metawave, Maha Achour, stated that the company will advance the radar capabilities in vehicles through its partnership with DENSO and through the telecom customers to render 5G solutions. Metawave wants to play a vital role in ensuring the safety on the roads.
 

Source Credits: https://www.prnewswire.com/news-releases/denso-leads-series-a-funding-round-for-smart-radar-startup-metawave-300951696.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Arranta Bio acquires Captozyme to accelerate microbiome development
Arranta Bio acquires Captozyme to accelerate microbiome development
By Mateen Dalal

Arranta has established a Center of Excellence for microbiome development   The acquisition will help quicken the delivery of LBPs for clients worldwide Arranta Bio, a leading Contract Development Manufacturing Organization, recently annou...

CytoDyn obtains IRB approval for leronlimab for patients with TNBC
CytoDyn obtains IRB approval for leronlimab for patients with TNBC
By Mateen Dalal

Reports confirm that CytoDyn Inc., a late-stage biotechnology company has announced that it has recently received approval from the Institutional Review Board for leronlimab, to be directed to triple-negative breast cancer (TNBC) patients under a com...

FDA declines approval of Lipocine’s oral drug Tlando for third time
FDA declines approval of Lipocine’s oral drug Tlando for third time
By Mateen Dalal

FDA declines approval of Lipocine’s oral drug Tlando for third time Reportedly, the oral drug Tlando was first declined  approval by FDA in the year 2016. The U.S. Food and Drug Administration (FDA)  declined the approval of oral dr...